BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17580175)

  • 1. Prevention of de novo hepatitis B virus infection by vaccination and high hepatitis B surface antibodies level in children receiving hepatitis B virus core antibody-positive living related donor liver: case reports.
    Jankowska I; Pawłowska J; Teisseyre M; Kaliciński P; Kamiński A; Czubkowski P; Cielecka-Kuszyk J; Kluge P; Pronicki M; Socha J
    Transplant Proc; 2007 Jun; 39(5):1511-2. PubMed ID: 17580175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance.
    Ghisetti V; Marzano A; Zamboni F; Barbui A; Franchello A; Gaia S; Marchiaro G; Salizzoni M; Rizzetto M
    Liver Transpl; 2004 Mar; 10(3):356-62. PubMed ID: 15004761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of de novo hepatitis B infection from HbcAb-positive donors in living donor liver transplantation.
    Lee KW; Lee DS; Lee HH; Kim SJ; Joh JW; Seo JM; Choe YH; Lee SK
    Transplant Proc; 2004 Oct; 36(8):2311-2. PubMed ID: 15561233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active immunization against de novo hepatitis B virus infection in pediatric patients after liver transplantation.
    Chang SH; Suh KS; Yi NJ; Choi SH; Lee HJ; Seo JK; Lee KU
    Hepatology; 2003 Jun; 37(6):1329-34. PubMed ID: 12774011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo infection of hepatitis B virus in patients with orthotopic liver transplantation: analysis by determining complete sequence of the genome.
    Rokuhara A; Tanaka E; Yagi S; Mizokami M; Hashikura Y; Kawasaki S; Kiyosawa K
    J Med Virol; 2000 Dec; 62(4):471-8. PubMed ID: 11074476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage.
    Fabrizio F; Bunnapradist S; Martin P
    J Nephrol; 2002; 15(6):605-13. PubMed ID: 12495272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical course of de novo hepatitis B infection after pediatric liver transplantation.
    Su WJ; Ho MC; Ni YH; Wu JF; Jeng YM; Chen HL; Wu YM; Hu RH; Chang MH; Lee PH
    Liver Transpl; 2010 Feb; 16(2):215-21. PubMed ID: 20104496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool.
    Donataccio D; Roggen F; De Reyck C; Verbaandert C; Bodeus M; Lerut J
    Transpl Int; 2006 Jan; 19(1):38-43. PubMed ID: 16359375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
    Xi ZF; Xia Q; Zhang JJ; Chen XS; Han LZ; Zhu JJ; Wang SY; Qiu DK
    J Dig Dis; 2013 Aug; 14(8):439-45. PubMed ID: 23638710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risks of HBV infection after liver transplantation from HBc antibody positive donor to HBs antibody positive recipient.
    Ikegami T; Taketomi A; Ohta R; Soejima Y; Yoshizumi T; Harada N; Shimada M; Maehara Y
    Hepatogastroenterology; 2008; 55(88):2162-5. PubMed ID: 19260497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B core antibody-positive grafts: recipient's risk.
    de Villa VH; Chen YS; Chen CL
    Transplantation; 2003 Feb; 75(3 Suppl):S49-53. PubMed ID: 12589141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
    Ueda Y; Marusawa H; Egawa H; Okamoto S; Ogura Y; Oike F; Nishijima N; Takada Y; Uemoto S; Chiba T
    Antivir Ther; 2011; 16(4):479-87. PubMed ID: 21685535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients.
    Veroux M; Puliatti C; Gagliano M; Cappello D; Macarone M; Vizcarra D; Spataro M; Di Mare M; Ginevra N; Veroux P
    Transplant Proc; 2005; 37(6):2574-5. PubMed ID: 16182748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor.
    Yu L; Koepsell T; Manhart L; Ioannou G
    Liver Transpl; 2009 Oct; 15(10):1343-50. PubMed ID: 19790164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of de novo hepatitis B infection in liver allograft recipients with previous hepatitis B infection or hepatitis B vaccination.
    Bárcena Marugán R; García-Hoz F; Vázquez Romero M; Nash R; Mateos M; González Alonso R; García González M; García Plaza A
    Am J Gastroenterol; 2002 Sep; 97(9):2398-401. PubMed ID: 12358263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of anti-hepatitis B core antibody-positive donors for living-donor liver transplantation.
    Hwang S; Moon DB; Lee SG; Park KM; Kim KH; Ahn CS; Lee YJ; Chu CW; Yang HS; Cho SH; Oh KB; Ha TY; Min PC
    Transplantation; 2003 Feb; 75(3 Suppl):S45-8. PubMed ID: 12589140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
    Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.